The safety and short‐term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID‐19-Reference-Cited by-同舟云学术

The safety and short‐term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID‐19

Published:2022-10-05 Issue:4 Volume:3 Page:
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Ding Yihan¹²³,Shen Yifan¹²,Fan Yi¹²,Chen Jia¹²,Xu Yang¹²,Wu Depei¹²

Affiliation:

1. National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China

2. Institute of Blood and Marrow Transplantation Collaborative Innovation Center of Hematology Soochow University Suzhou China

3. Department of Hematology The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University Huai'an China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.179

Reference10 articles.

1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

2. Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults

3. Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021

4. The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines

5. Safety and Efficacy of the Common Vaccines against COVID-19